Pharmacy Financial Model Template in Excel

What you'd spend hiring a freelance analyst: $2,000+. What you'd spend building it yourself: a week.
Pharmacy Financial Model overview image showing key sections and what the model helps users accomplish: consolidated KPIs, runway/cash visibility, customizable inputs, scenario-ready forecasts for pharmacy financial planning
Fully Editable
Instant Download
Professional Design
Pre-Built
No Expertise Is Needed
Pharmacy Financial Model overview image showing key sections and what the model helps users accomplish: consolidated KPIs, runway/cash visibility, customizable inputs, scenario-ready forecasts for pharmacy financial planning
Industry Benchmarks
Projected balance sheet
Capital expenditure plan
Capitalization table
Cash flow forecast
Financial charts
COGS & Operating expense forecast
Financial model dashboard
DuPont analysis
Projected income statement
Payroll forecast
Financial ratio analysis
Return on invested capital analysis
Revenue forecast
Financial scenario analysis
Sources and uses of funds
Financial model summary
Top expense analysis
Top revenue streams
Business valuation analysis
Fully Editable
Instant Download
Professional Design
Pre-Built
No Expertise Is Needed
Pharmacy Bundle
See included products:
Financial Model iPharmacy Bundle Financial Model template included in this product.
$149 $109
ADD TO YOUR ORDER
Business Plan iPharmacy Bundle Business Plan template included in this product.
$79 $59
Pitch Deck iPharmacy Bundle Pitch Deck template included in this product.
$49 $29
YOU SAVE $0 TODAY
30-Day Money-Back Guarantee
Created by a Former CFO
Updated for 2026
One-Time Purchase
Description

This Pharmacy Financial Model is an Excel template for planning an independent US community pharmacy from 2026 through 2030. It connects monthly purchasing customers, items sold, realized receipts, merchandise costs, pharmacy staffing, and overhead to projected operating EBITDA.

The illustrative case is a leased, approximately 1,800-square-foot suburban store with insured and cash prescriptions plus a small retail front end. Prices and reimbursement assumptions are editable estimates, not a representation of any particular payer contract, pharmacy, or local market.

Forecast
5annual periods
Revenue streams
5sales categories
Units per customer
3monthly planning input
WORKBOOK CONTENTS

What Is Included in the Pharmacy Model?

The workbook brings prescription and front-end sales planning together with cost schedules, staffing, startup investment, financing controls, and financial reporting.

Revenue and Calc

Edit purchasing customers, units per customer, sales mix, receipts, and launch timing. Calc converts volume inputs into five monthly revenue streams.

COGS & OPEX and Payroll

Budget drug acquisition, dispensing materials, processing fees, fixed overhead, and FTE salaries without double-counting payroll.

CAPEX, CapTable and Debt

Schedule opening assets, owner equity, and optional debt. Dashboard controls feed repayment and financing cash-flow schedules.

Financial and decision reports

Inspect the Income Statement, Cash Flow, Balance Sheet, Summary, Scenarios, Returns, Valuation, Sources & Uses, and Checks for reporting and decisions.

REVENUE ENGINE

How Does the Model Forecast Pharmacy Sales?

Purchasing customers multiplied by units per customer form one demand-based sales pool allocated across five priced categories.

In 2026, 800 monthly purchasing customers buy an estimated three units each, creating 2,400 units. The monthly customer assumption grows to 1,100, 1,400, 1,700, and 1,900 for 2027–2030.

Unit shares: 66% generic prescriptions at $35, 14% brand at $260, 10% OTC at $14, 6% vitamins at $20, and the residual 4% health supplies at $25. All receipts are estimated per purchased unit.

Revenue Forecast

The Revenue Forecast applies customer volumes, units per customer, category shares, and realized prices to annual sales. Calc handles monthly timing, including zero revenue before launch and a full launch month.

pharmacy financial model revenue fml30
Illustrative 2026 monthly revenue

800 customers × 3 purchased units × $63.10 weighted receipt = $151,440 per month; 12 months = $1,817,280 in 2026.

The $63.10 weighted receipt applies once to the shared unit pool. Modeled receipts are net of payer concessions, and the plan imposes neither a separate capacity limit nor material monthly seasonality.

Change volume, mix, and receipts to test sales sensitivity; the estimates do not represent negotiated pharmacy reimbursement.

OPERATING COSTS

How Are Drug Costs and Payroll Calculated?

Direct acquisition and dispensing costs, other variable expenses, fixed overhead, and base payroll are calculated separately before EBITDA.

Estimated COGS equals 80.3% for acquisition, 0.3% for bottles and labels, and 0.4% for expiry and shrink: 81% of revenue in total.

Card processing (0.6%), claims switching (0.2%), and marketing (0.4%) produce 1.2% variable expenses. Annual fixed expenses are $93,600, including $3,600 monthly rent plus utilities, insurance, compliance, maintenance, and administrative services.

COGS and Operating Expenses

The COGS and Operating Expenses forecast separates acquisition, revenue-linked operating charges, and fixed overhead. Test how reimbursement and purchasing costs affect margins before payroll.

pharmacy financial model cogs opex fml30

In 2026, staffing comprises 1.4 pharmacist FTE at $140,000 per FTE, 2 technician FTE at $43,000, and 0.6 clerk FTE at $34,000. Salaries are not part of COGS.

Base payroll rises from $302,400 in 2026 to $351,500 in 2030 as role-level FTE assumptions change. Each salary is counted once, separate from variable and fixed store costs.

Payroll Forecast by Staff Role

The Payroll Forecast calculates personnel costs from FTE and role salaries. The workbook also provides hiring, bonus, and payroll-tax settings, although this example excludes employer taxes and benefits.

pharmacy financial model payroll fml30
STARTUP AND FUNDING

What Startup Investment Does the Model Track?

Opening equipment and improvements, prelaunch cash costs, working capital, and initial owner funding are planned outside recurring operating EBITDA.

Four quantified opening assets total $116,500: $70,000 in improvements, $22,000 in fixtures, $18,000 in computer and dispensing hardware, and $6,500 in refrigeration. Safes, cameras, and signage are additional assets without specified amounts.

Prelaunch permits, deposits, software setup, training, wages, and launch marketing are separate opening cash uses, not annual operating expenses or EBITDA deductions.

Capital Expenditure Plan

The Capital Expenditure Plan schedules pharmacy equipment and improvements by date and depreciability. It distinguishes asset investment cash outlays from ongoing operating costs.

pharmacy financial model capex fml30

Estimated owner funding is $757,890, covering opening assets, prelaunch cash, opening net working capital, and a three-month operating reserve. The reserve is policy, not verified peak-cash sufficiency.

Working-capital inputs assume 12 receivables days, 15 payables days, and 30 inventory days. They change projected cash timing without automatically changing EBITDA.

Sources and Uses of Funds

Sources and Uses of Funds reconciles equity and optional debt with operating payments, investment, and retained cash. It helps compare the revised opening investment against planned funding.

pharmacy financial model sources uses fml30
FIVE-YEAR PROJECTIONS

What Does the Example Pharmacy Forecast Show?

The documented illustrative Base operating case shows rising annual revenue and EBITDA as monthly purchasing-customer assumptions increase.

Illustrative pharmacy operating forecast, USD
Year Revenue Operating Expenses EBITDA
2026 $1,817,280 $1,889,804 -$72,524
2027 $2,498,760 $2,455,081 $43,679
2028 $3,180,240 $3,039,557 $140,683
2029 $3,861,720 $3,611,734 $249,986
2030 $4,316,040 $3,992,885 $323,155

Illustrative projections, rounded to whole dollars. Operating expenses include COGS, variable, fixed, and payroll costs.

The example moves from negative $72,524 EBITDA in 2026 to $323,155 in 2030, as annual revenue reaches $4,316,040 under the selected assumptions.

EBITDA is neither net profit nor cash. The Income Statement, Cash Flow, and Balance Sheet model additional financial measures, but the supplied case establishes no net income or closing cash figures.

Cash Flow Forecast

The Cash Flow Forecast separates operating cash, purchases, equity and debt movements, and opening-to-closing balances. Consult it for liquidity rather than treating EBITDA as available cash.

pharmacy financial model cf fml30
DECISION ANALYSIS

How Can You Evaluate Break-Even and Payback?

The workbook separates operational sales thresholds from cash recovery, financing requirements, and returns on invested capital.

Returns distinguishes sales break-even, cash break-even, investment payback, and annual ROIC. These address cost coverage, cash recovery timing, invested capital recovery, and capital productivity.

The supplied case establishes no payback month, ROIC, IRR, or discounted value; none can be inferred solely from EBITDA.

Break-Even, Payback and ROIC

The Returns report analyzes operating sales thresholds, project free cash flow, payback, and annual ROIC. Enter pharmacy-specific investments and cash assumptions before using its outputs for decisions.

pharmacy financial model returns fml30

Dashboard Scenario Controls apply Low, Base, and High multipliers to revenue and all four cost layers. Scenarios compares operating margins and EBITDA; Debt and Valuation support separate financing decisions.

PRACTICAL USE

Who Can Use This Pharmacy Financial Template?

Designed for independent pharmacy operators, prospective buyers, and advisers testing conventional retail dispensing economics.

Test prescription mix, customer capture, FTE coverage, and startup funding. Specialty dispensing, compounding, mail order, clinical services, delivery sales, and franchise fees are outside this case.

Replace estimates with payer contracts, supplier quotes, lease terms, wage requirements, licensing costs, and opening inventory before relying on the projections.

FREQUENTLY ASKED QUESTIONS

Pharmacy Financial Model FAQs

These answers clarify how to adapt the forecast, what the illustrative figures represent, and which reports answer common planning questions.

Can I change prescription and front-end sales assumptions?

Yes. Edit purchasing customers, purchased units per customer, generic and brand shares, retail category shares, and realized unit receipts in the Revenue inputs.

Does the forecast model payer reimbursement contracts?

It uses estimated realized per-unit receipts net of concessions, not an independently verified insurer, PBM, or Medicaid reimbursement contract.

Are pharmacist and technician salaries included?

Yes. Base pay is planned in Payroll by full-time-equivalent role, and the illustrated costs do not count those salaries again in COGS or fixed overhead.

Are startup purchases part of EBITDA?

No. Opening assets and prelaunch cash uses are tracked separately; depreciation and investment cash flows appear in their corresponding financial reports.

Can I analyze cash needs or debt financing?

Yes. Cash Flow, Sources & Uses, and Debt schedules support liquidity and financing analysis, but the supplied reserve is not a tested peak-cash sufficiency result.

Does positive EBITDA mean the investment pays back?

No. Sales break-even, cash break-even, project payback, and ROIC require distinct calculations in Returns and cannot be inferred from EBITDA alone.

Are the five-year figures pharmacy industry averages?

No. They are illustrative 2026–2030 projections based on estimated assumptions for one independent suburban US pharmacy, not observed industry results.

What Does the Pharmacy Financial Model Contain?

pharmacy financial model dashboard fml30

Financial Dashboard

KPIs, forecasts, and cash flow at a glance.

pharmacy financial model revenue fml30

Revenue Engine

Key assumptions and calculations driving revenue forecasts.

pharmacy financial model sources uses fml30

Sources & Uses

Funding sources, spending, and closing cash.

pharmacy financial model returns fml30

Returns & Break-Even

Cash break-even, payback, and ROIC.

pharmacy financial model valuation fml30

Business Valuation

DCF valuation and sensitivity analysis.

pharmacy financial model top expenses fml30

Expense Breakdown

Largest costs and spending trends.

pharmacy financial model summary fml30

Financial Summary

Annual and monthly financial performance.

pharmacy financial model benchmarks fml30

KPI Benchmarks

Compare margins and returns to benchmarks.

Trusted by 25,000+ startup founders, investors and CPAs

Clear Assumptions At a Glance

Megan Carter, TX

4 star rating

It brought pricing, costs, and growth assumptions into one place, so I stopped bouncing between tabs. I saved about 4 hours on my first pass and could finally explain every number without second-guessing it.

Runway Became Easy To See

Derek Johnson, FL

5 star rating

The cash-flow tabs made runway and shortfalls much easier to track. I booked a lender meeting the same day because I could show when cash would tighten and what funding gap I actually needed.

Margins And Break-Even Stood Out

Priya Shah, NJ

5 star rating

I could see margins and break-even without digging through formulas, which made the model far easier to use. It cut my review time by a couple of hours and gave me a cleaner base for pricing decisions.